You are here Home Guidance and resources Sponsors Celltrion Healthcare Australia Pty Ltd. Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Prescription medicine decision summary (2) Date 2023 (1) 2021 (1) Results for "[search-keyword]" Search Sponsor content2 result(s) found, displaying 1 to 2 Vegzelma 18 September 2023 Prescription medicine decision summary Vegzelma (bevacizumab) is approved to treat cancer. Regkirona 6 December 2021 Prescription medicine decision summary Australian prescription medicine decision summary
Vegzelma 18 September 2023 Prescription medicine decision summary Vegzelma (bevacizumab) is approved to treat cancer.
Regkirona 6 December 2021 Prescription medicine decision summary Australian prescription medicine decision summary